EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
European Association for the Study of the Liver.
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial.
Lim YS, Yu ML, Choi J, Chen CY, Choi WM, Kang W, Kim GA, Kim HJ, Lee YB, Lee JH, Park NH, Kwon SY, Park SY, Kim JH, Choi GH, Jang ES, Chen CH, Hsu YC, Bair MJ, Cheng PN, Tung HD, Chang TS, Lo CC, Tseng KC, Yang SS, Peng CY, Han S.
Lancet Gastroenterol Hepatol. 2025 Apr;10(4):295-305. doi: 10.1016/S2468-1253(24)00431-X. Epub 2025 Feb 3.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, Kim HY, Kim TH, Yoon EL, Jun DW, Ahn SH, Sypsa V, Yurdaydin C, Lampertico P, Calleja JL, Janssen H, Dalekos GN, Goulis J, Berg T, Buti M, Kim SU, Kim YJ.
J Hepatol. 2024 Jan;80(1):20-30. doi: 10.1016/j.jhep.2023.09.011. Epub 2023 Sep 19.
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
Choi WM, Kim GA, Choi J, Choi GH, Lee YB, Sinn DH, Lim YS.
Gut. 2024 Mar 7;73(4):649-658. doi: 10.1136/gutjnl-2023-330225.
[Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
Cullu F, Tümay GT, Kutlu T, Erkan T, Ozbay G, Badur S.
Gastroenterol Clin Biol. 1995 Jan;19(1):53-7.
Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.
Yu R, Fan R, Hou J.
Front Med. 2014 Jun;8(2):135-44. doi: 10.1007/s11684-014-0331-5. Epub 2014 May 8.
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection.
Tajiri K, Hayashi Y, Murayama A, Muraishi N, Minemura M, Yasuda I.
Viruses. 2024 Dec 31;17(1):44. doi: 10.3390/v17010044.
Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases.
Keeffe EB.
Trans Am Clin Climatol Assoc. 2006;117:227-37; discussion 237-8.
Hepatitis B: Who and when to treat?
Vlachogiannakos J, Papatheodoridis GV.
Liver Int. 2018 Feb;38 Suppl 1:71-78. doi: 10.1111/liv.13631.
Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination.
Keeffe EB.
Am J Med. 2005 Oct;118 Suppl 10A:21S-27S. doi: 10.1016/j.amjmed.2005.07.013.
